Effects of β-Lapachone at Non-Toxic and Toxic Concentrations on the mRNA Levels of XRCC1, GADD45A and LIG4 Genes

  • Fatemeh SANIE-JAHROMI Department of Biology, College of Sciences, Shiraz University, Shiraz, Iran
  • Hamideh MAHMOUDINASAB Department of Biology, College of Sciences, Shiraz University, Shiraz, Iran
  • Mostafa SAADAT Department of Biology, College of Sciences, Shiraz University, Shiraz, Iran

Abstract

No Abstract

References

1. Ladeira C, Viegas S, Pádua M et al (2014). Assessment of genotoxic ef-fects in nurses handling cytostatic drugs. J Toxicol Environ Health A, 77(14-16):879-87.
2. Bentle MS, Reinicke KE, Dong Y et al (2007). Non-homologous end joining is essential for cellular resistance to the nov-el antitumor agent, beta-lapachone. Cancer Res, 67(14):6936-45.
3. Robins P, Lindahl T (1996). DNA ligase IV from HeLa cell nuclei. J Biol Chem, 271(39):24257-61.
4. Chakrabarti G, Silvers MA, Ilcheva M et al (2015). Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone. Sci Rep, 5:17066.
5. Hollander MC, Sheikh MS, Bulavin DV et al (1999). Genomic instability in Gadd45a-deficient mice. Nat Genet, 23(2):176-84.
6. Sanie-Jahromi F, Saadat I, Saadat M (2016). Effects of extremely low frequency elec-tromagnetic field and cisplatin on mRNA levels of some DNA repair genes. Life Sci, 166: 41-5.
Published
2019-03-12
How to Cite
1.
SANIE-JAHROMI F, MAHMOUDINASAB H, SAADAT M. Effects of β-Lapachone at Non-Toxic and Toxic Concentrations on the mRNA Levels of XRCC1, GADD45A and LIG4 Genes. Iran J Public Health. 48(3):559-60.
Section
Letter to the Editor